Featured Research

from universities, journals, and other organizations

Study Identifies Genetics Of Fat Metabolism, Red Wine Link

Date:
July 9, 2004
Source:
Oregon State University
Summary:
A new study has found that a gene called SIRT1 can reduce the development of new fat cells and increase the metabolism or use of fat within existing fat cells. SIRT1 is the topic of considerable recent research, and other studies have also shown that its activity level can be significantly increased by the presence of a compound found in red wine.

CORVALLIS, Ore. – A new study has found that a gene called SIRT1 can reduce the development of new fat cells and increase the metabolism or use of fat within existing fat cells.

SIRT1 is the topic of considerable recent research, and other studies have also shown that its activity level can be significantly increased by the presence of a compound found in red wine.

The new research, done by scientists from Oregon State University, the Massachusetts Institute of Technology and the University of Ottawa, was recently published in the journal Nature.

It may help explain, researchers say, why moderate consumption of red wine appears to reduce deaths from heart disease, as has been suggested by some demographic studies.

The study was done with mice as a research model, and a remaining challenge will be to see if the same results are observed in a higher vertebrate model, including humans.

The research outlined the processes of fat formation and usage at a cellular and genetic level. It also analyzed the metabolic function of resveratrol, a polyphenol and antioxidant found at high levels in grape skins.

"When cells were exposed to resveratrol, our studies showed a pretty dramatic reduction in the conversion to fat cells and a lesser but still significant increase in the mobilization of existing fat, or the rate at which the cells metabolized stored fat," said Mark Leid, a professor of pharmacology in the OSU College of Pharmacy. "This clearly could be one of the explanations for the health benefits that some researchers believe can be linked to moderate red wine consumption."

A range of studies, the OSU and MIT researchers said, have demonstrated that caloric restriction is one of the few proven methods to retard aging, improve cardiovascular health and extend mammalian lifespan.

Research done with yeast has shown that a gene called SIR2 tends to promote longevity, and that yeast cells die prematurely if this gene is deleted, Leid said. Previous studies have shown that resveratrol can increase the activity of SIR2 and increase the lifespan of yeast cells up to 70 percent. And it has also been found that SIRT1, a gene found in both mice and humans, has essentially the same function as SIR2 and the same reaction to stimulus by resveratrol.

In trying to determine the molecular basis for this genetic link to longevity, the new study found that SIRT1 increases the use of fat and reduces the formation of new fat cells – apparently it represses one or more fat-regulating proteins and other genes that drive fat storage following calorie restriction. This may have been an evolutionary adaptation for the body to sense short term famine and counter it by increasing the burning of stored body fat, researchers say.

The increased activity of SIRT1 in the presence of resveratrol is clearly of interest, the researchers said, but it's too early to be certain of its effects in humans.

"It would be very premature to suggest that supplements of resveratrol would have any benefits, because this compound oxidizes very quickly and easily loses its metabolic effectiveness," Leid said. "Because of that we have a hard time even studying it in a laboratory setting. But we do know that red wine has fairly high levels of the compound, and this study would suggest at least one mechanism for possible health benefits of red wine. It may help prevent fat development and storage."

Resveratrol is found in the skins of grapes, and its concentration in wine is a reflection of the time the skins are present during the fermentation process – because of that, the levels are much higher in red wine than in white wine or other products. Other sources of the compound include mulberries, peanuts, and some other plants.


Story Source:

The above story is based on materials provided by Oregon State University. Note: Materials may be edited for content and length.


Cite This Page:

Oregon State University. "Study Identifies Genetics Of Fat Metabolism, Red Wine Link." ScienceDaily. ScienceDaily, 9 July 2004. <www.sciencedaily.com/releases/2004/07/040709085724.htm>.
Oregon State University. (2004, July 9). Study Identifies Genetics Of Fat Metabolism, Red Wine Link. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2004/07/040709085724.htm
Oregon State University. "Study Identifies Genetics Of Fat Metabolism, Red Wine Link." ScienceDaily. www.sciencedaily.com/releases/2004/07/040709085724.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins